Poor Pregnant Women with Herpes Don’t Get Meds, and Someone Notices

Let our journalists help you make sense of the noise: Subscribe to the Mother Jones Daily newsletter and get a recap of news that matters.

GlaxoSmithKline, in testing their herpes med, Valtrex, may have put women in harm’s way. This according to Public Citizen, which, in the Dec 1 issue of Obstetrics and Gynecology accuses the pharma giant of withholding important medication from poor and minority women.

In a recent clinical trial 168 pregnant women were given a placebo rather than an alternative herpes drug, while the other 170 were given medication. This, despite the fact that research has shown that the drug and its generic, acyclovir, reduces risks associated with herpes and pregnancy (the virus can be fatal for infants who contract the disease at birth).

The study, which took place earlier this year and was funded by GlaxoSmithKline, enrolled more than 300 black and Hispanic pregnant women at Parkland Hospital in Dallas. The hospital serves a largely indigent population. Public Citizen’s Dr. Peter Lurie is outraged:

“What I don’t understand is how you can do a research study and conclude that a drug is effective and then stare a bunch of pregnant women in the face and withhold the very drug you’ve just recommended.”

A doctor involved in the study, Dr. George Wendel, would not comment specifically on allegations that poor women were taken advantage of, instead saying that the study was designed and conducted “according to good research practices” and was approved by the hospital’s ethics review board.


Headshot of Editor in Chief of Mother Jones, Clara Jeffery

It sure feels that way to me, and here at Mother Jones, we’ve been thinking a lot about what journalism needs to do differently, and how we can have the biggest impact.

We kept coming back to one word: corruption. Democracy and the rule of law being undermined by those with wealth and power for their own gain. So we're launching an ambitious Mother Jones Corruption Project to do deep, time-intensive reporting on systemic corruption, and asking the MoJo community to help crowdfund it.

We aim to hire, build a team, and give them the time and space needed to understand how we got here and how we might get out. We want to dig into the forces and decisions that have allowed massive conflicts of interest, influence peddling, and win-at-all-costs politics to flourish.

It's unlike anything we've done, and we have seed funding to get started, but we're looking to raise $500,000 from readers by July when we'll be making key budgeting decisions—and the more resources we have by then, the deeper we can dig. If our plan sounds good to you, please help kickstart it with a tax-deductible donation today.

Thanks for reading—whether or not you can pitch in today, or ever, I'm glad you're with us.

Signed by Clara Jeffery

Clara Jeffery, Editor-in-Chief

payment methods

We Recommend